For example, it has been reported that miR-2682-3p could inhibit osteosarcoma cell proliferation by targeting CCND2 (Cyclin D2), MMP8 (Matrix metallopeptidase 8), and Myd88 (Myeloid differentiation primary response gene 88) [15]. This evidence concerns the gene MMP8 and osteosarcoma.